Depen (Meda Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Depen drug offered from Meda Pharmaceuticals Inc.. This Antirheumatic Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Meda Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Penicillamine
SUBSTANCE NAME: PENICILLAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antirheumatic Agent [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1978-11-30
END MARKETING DATE: 0000-00-00


Depen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDepen from Meda Pharmaceuticals Inc.
LABELER NAME: Meda Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 1978-11-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0037-4401_8afdaf40-dcb8-11e1-baf1-0002a5d5c51b
PRODUCT NDC: 0037-4401
APPLICATION NUMBER: NDA019854

Other PENICILLAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aton Pharma, Inc.Cuprimine
Meda Pharmaceuticals Inc.Depen